BUDESONIDE SPRAY PER COVID-19: RIDUZIONE DEL 2% DI RICOVERO O DECESSO NEL PAZIENTE A DOMICILIO A RISCHIO DI COMPLICANZE
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Ly-Mee Yu, et al. Summary Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in patients not admitted to hospital, but effectiveness in high-risk individuals is unknown.…

